Current Region: Global
[Close]
Your selections will be saved and used to recommend products based on your interests.
MM-DD-YYYY
Global Forum
Optimal Allocation of Prognostic Factors in Randomized Preclinical Animal StudiesZheng SuDrug Information Journal
Optimal Allocation of Prognostic Factors in Randomized Preclinical Animal Studies Drug Information Journal
Review of: Fundamentals of US Regulatory Affairs, 7th ed. Edward TaborDrug Information Journal
Certification for the Medical Science Liaison: An Idea Whose Time Has come---or NotKenneth L Massey,Jane Chin,Jimmy Thomas BlackDrug Information Journal
Medical Information Services in the Age of Social Media and New Customer ChannelsLesley S. Fierro,Poonam A. Bordoloi,Michelle Clausen,Krupa Paranjpe,Andrew GazoDrug Information Journal
Clinically Important Effects in New Drug DevelopmentSatoshi Hashigaki,Kanae Togo,Takashi Moriya,Keiji ImaiDrug Information Journal
Assessment of Electronic Drug Information Research Availability in Alabama PharmaciesMichael G Kendrach,Bob Schrimsher,Maisha Kelly FreemanDrug Information Journal
Content Analysis of Off-label Drug Use: Reporting Print Media CoverageDavid A. Holdford,Avani D JoshiDrug Information Journal
Failure to Communicate: Medication Guide or Memory ?Louis A Morris,Morris S WhitcupDrug Information Journal
Evaluation of Drug Adverse Event Intake and Reporting in a Medical Information ServiceRobert J. Fuentes,Michael Hoopes,Gregory M Susla,Pamela D AllenDrug Information Journal
Validation of Decision-enabling Tools: Showing That the Model Is UsefulStig J WiklundDrug Information Journal
A Benefit-risk Model to Facilitate DMC-sponsor Communication and Decision MakingAndreas I. SashegyiDrug Information Journal
Letter to the Editor: Selection of the Time Points for a Thorough QTc StudyNorman Stockbridge,Joanne ZhangDrug Information Journal
A Longitudinal Model and Graphic for Benefit-risk Analysis, With Case StudyJonathan D. NortonDrug Information Journal
Platelet Aggregation Quality Control in a Multicenter Phase 2 Clinical TrialJames McRedmondDrug Information Journal
Ten-year Experience of the Evaluation of Ethnic Sensitivity DataChia-Ling HsiaoDrug Information Journal
Letter to the EditorDrug Information Journal
Fewer Drugs, Shorter Lives, Less Prosperity: The Impact of Comparative Effectiveness Research on Health and WealthPeter J. PittsDrug Information Journal
Preparing for a Safety InspectionSteve JolleyDrug Information Journal
Associate Editor's Commentary: The Danger of Shorting Drug ShortagesPeter J. PittsDrug Information Journal
Commentary: The Real-world Convergence of Comparative Effectiveness Research and Risk- Benefit AssessmentJohn DoyleDrug Information Journal
Editor's Commentary: A Time for Reflection and AnticipationRick TurnerDrug Information Journal
Benefit/Risk Estimates in Clinical TrialsAdil E. ShamooDrug Information Journal
Japanese Guideline on Global Clinical Trials: Statistical Implications and Alternative Criteria for Assessing ConsistencyFlorence Le Maulf,Kevin J. CarrollDrug Information Journal
Decision Making for a Companion Diagnostic in an Oncology Clinical Development ProgramBernard Fine,Lee KaiserDrug Information Journal
Establishing a Complete Drug Information Triad: Academic, Industry, and Hospital TrainingElizabeth S Miller,Katie J. Suda,Anne M. Hurley,Mina Tadrous,Daniel GharbawyDrug Information Journal
Reporting of Adverse Drug Reactions by Community Pharmacists: A Qualitative Study in QuebecBenoit RouleauDrug Information Journal
Technical Requirements for Biopharmaceutics Classification System–based Biowaiver in ChinaNing ZhangDrug Information Journal
Results of a Survey of PhRMA Member Companies on Practices Associated With Multiregional Clinical TrialsNick R Scott,Tonya L Houck,Yoko Tanaka,Bruce Binkowitz,Belinda Field,Ekopimo O. Ibia,Andy Lee,Steven TalericoDrug Information Journal
Consistency of Treatment Effect Across Regions in Multiregional Clinical Trials, Part 2: Monitoring, Reporting, and InterpretationSoo P. Ouyang,Paul P. Gallo,Shailendra S. Menjoge,Yoko Tanaka,Bruce Binkowitz,Ekopimo O. Ibia,Gang Li,Hui Quan,Xiaolong Luo,Joshua Chen,Steven Talerico,Kimitoshi IkedaDrug Information Journal
Consistency of Treatment Effect Across Regions in Multiregional Clinical Trials, Part 1: Design ConsiderationsSoo P. Ouyang,Paul P. Gallo,Shailendra S. Menjoge,Yoko Tanaka,Bruce Binkowitz,Ekopimo O. Ibia,Gang Li,Hui Quan,Xiaolong Luo,Joshua Chen,Steven Talerico,Kimitoshi IkedaDrug Information Journal
Impact of Different Regulatory Requirements for Trial Endpoints in Multiregional Clinical TrialsCynthia J. Girman,Shailendra S. Menjoge,Bruce Binkowitz,Carmen Mak,Anupam Agarwal,Ekopimo O. Ibia,Joshua ChenDrug Information Journal
Points to Consider in Defining Region for a Multiregional Clinical Trial: Defining Region Work Stream in PhRMA MRCT Key Issue TeamMichael A Rabbia,Yoko Tanaka,Bruce Binkowitz,Carmen Mak,Ekopimo O. Ibia,Brent Burger,Joshua Chen,Alex ZolotovitskiDrug Information Journal
Multiregional Clinical Trials: An Introduction From an Industry PerspectiveBruce Binkowitz,Ekopimo O. IbiaDrug Information Journal
Letters to the EditorNorman Stockbridge,Lawrence Z Satin,Eoin O'BrienDrug Information Journal
Program Chair Reflects Upon DIA 2011Kenneth A. GetzDrug Information Journal
Editor's Commentary: Letters to the Editor, a New Publishing Partner, and Benefit-risk EstimationRick TurnerDrug Information Journal
DIA 2011 47th Annual Meeting Student Poster AbstractsNicholas H. Schluterman,Anne-Sophie Auroux,Mohammed Hamdan Al Rubaie,Jie Rena Sun,Jingjing Liu,Kaushal Vinaykumar Sheth,Gabriel Meister,Brian Claggett,Danish Arora,Manasi Datar,Shaunak Praful Kulkarni,Michelle P. Pernice,Andrew W. York,Digvijay Chandrakant Yeola,Joseph Mburu,Nikita SomaniDrug Information Journal
Expediting Patient Access to New Medicines: A Call to Action, London, January 26-27, 2010Peter J. Pitts,Werner Cautreels,Mary BakerDrug Information Journal
5th Annual Cardiovascular Risk Assessment Summit Lawrence Z Satin,David E. GutsteinDrug Information Journal
Review of the 9th Middle East Regulatory ConferenceAdrian Ball,Mike Stuart FallowsDrug Information Journal
Review of International Pharmaceutical Product Registration, 2nd ed.Edward TaborDrug Information Journal
Implementation of an Electronic Medical Information Request System for Field-generated Information InquiriesRommel Fernandez,Barbara Schreiner,Edward Bezarro,Helen Yin Yu,Jimmy Thomas BlackDrug Information Journal
Effect of Direct-to-Consumer Drug Advertising Exposure on Information SearchClive Mario Mendonca,David J McCaffrey,Benjamin F. Banahan III,Jonn P. Bently,Yi YangDrug Information Journal
Using Real-time Data to Drive Better Decisions, FasterPaula Brown Stafford,Andrew GarrettDrug Information Journal
Covariate-adjusted Difference in Proportions From Clinical Trials Using Logistic Regression and Weighted Risk DifferencesMiaomiao Ge,L. Kathryn Durham,R. Daniel Meyer,Wangang Xie,Neal ThomasDrug Information Journal
Multiple-stage Sampling Procedure for Lot Release With Consideration of oth Manufacturer's and Consumer's RiskBoguang Zhen,Tie-Hua Ng,Henry HsuDrug Information Journal
Optimal Sample Size Allocation in a Thorough QTc StudyJoanne ZhangDrug Information Journal
Are Pharmacists a Viable Channel for Education About Clinical Trial Participation?Diane Simmons,Jill Chappell,Kenneth A. Getz,Zachary P Hallinan,Brian P. Schrock,Dorothy L SmithDrug Information Journal
Phase 2 Clinical Development in Treating Chronic DiseasesNaitee TingDrug Information Journal
Evaluation of Data Entry Errors and Data Changes to an Electronic Data Capture Clinical Trial DatabaseJules T. Mitchel,Yong Joong Kim,Joonhyuk Choi,Glen D Park,Silvana Cappi,David Horn,Morgan Kist,Ralph B. D'AgostinoDrug Information Journal
Variability in Protocol Design Complexity by Phase and Therapeutic AreaKenneth A. Getz,Rafael A. Campo,Kenneth I. KaitinDrug Information Journal
Editor's Commentary: Additional Associate Editors, New Submission Category, and Meta-methodologyRick TurnerDrug Information Journal
Global Pharmaceutical Forum (In Chinese)